Serum human growth hormone (hGH) assays show a wide range in bias and in cut-off values for provocative tests, which vary from 13·5 to 35–40 mU/L when they have been established. Studies using novel hGH assays show that methods that are absolutely specific for 22-kDa hGH may not identify bioactive hGH peaks and that 20:22-kDa hGH ratios are increased in acromegaly. Greater harmonization of serum hGH methods can be achieved by: changing from IS 80/505 to IS 98/574, which is calibrated in mass units of recombinant 22-kDa hGH; using monoclonal/polyclonal or polyclonal/polyclonal antibody combinations that measure both 20-kDa and 22-kDa hGH; the development of assays such as the immunofunctional hGH assay which has the convenience of an immunometric assay but gives results that correlate better with bioassays; collaboration between manufacturers and laboratories to establish method-related cut-off limits for provocative tests of hGH status.
References
1.
CasanuevaFF. Physiology of growth hormone secretion and action. Endocrinol Metab Clin North Am1992;21: 483–518.
2.
LewisUJSinghRNPBonewaldLFLewisLJVanderlaanWP. Human growth hormone: additional members of the complex. Endocrinology1979;104: 1256–65.
3.
SinghRNPSeaveyBKLewisLJLewisUJ. Human growth hormone peptide 1-43: isolation from pituitary glands. J Protein Chem1983;2: 425–36.
4.
SinhaYNJacobsenBP. Human growth hormone (hGH)-(44-191), a reportedly diabetogenic fragment of hGH, circulates in human blood: measurement by radioimmunoassay. J Clin Endocrinol Metab1994;78: 1411–8.
5.
BaumannG.Growth hormone heterogeneity in human pituitary and plasma. Horm Res1999;51 (Suppl 1): 2–6.
6.
StolarMWAmburnKBaumannG.Plasma ‘big’ and ‘big-big’ growth hormone (GH) in man: an oligomeric series composed of structurally diverse GH monomers. J Clin Endocrinol Metab1984;59: 212–8.
7.
LiCH. Human growth hormone: perspective on its chemistry and biology. In: RaitiS, editor. Advances in Human Growth Hormones Research. Washington DC: Department of Health. DHEW publication no (NIH): 74-612, 1974: 321–41.
8.
BrostedtPLathamMWideLWernerSRoosP.Isolation of dimeric forms of pituitary growth hormone by bioassay, radioreceptor assay and radioimmunoassay. Acta Endocrinol (Copenh)1990;122: 241–8.
9.
LewisUJPetersonSMBonewaldLFSeavetBKVanderlaanWP. An interchain disulphide dimer of human growth hormone. J Biol Chem1977;252: 3697–702.
HindmarshPCMatthewsDBrainCEPringlePJDi SilvioLKurtzABThe half life of exogenous growth hormone after suppression of endogenous growth hormone secretion with somatostatin. Clin Endocrinol1989;30: 443.
12.
FrankenneFClossetJGomezFScippoMLHennanG.The physiology of growth hormones (GHs) in pregnant women and partial characterisation of the placental GH variant. J Clin Endocrinol Metab1988;66: 1171–80.
13.
BaumannGShawMAAmburnK.Regulation of plasma growth hormone-binding proteins in health and disease. Metabolism1989;38: 683–8.
KratzchJSeliskoTBirkenmeierG.Identification of transformed alpha 2-macroglobulin as a growth hormone binding protein in human blood. J Clin Endocrinol Metab1995;80: 583–90.
16.
EaleyPAYatemanMEHoltSJMarshallNJ. ESTA: a bioassay system for the determination of the potencies of hormones and antibodies which mimic their action. J Mol Endocrinol1988;1: R1–R4.
17.
DattaniMTHindmarshPCPringlePJBrookCGDMarshallNJ. The measurement of growth hormone bioactivity in patients' serum using an eluted stain assay. J Clin Endocrinol Metab1995;80: 2675–83.
18.
DattaniMTWinrowAPTuil PakovAPringlePJHindmarshPCBrookCGDEvaluation of growth hormone (GH) responses to pulsed GH-releasing hormone administration using the MTT-ESTA bioassay. Eur J Endocrinol1996;135: 87–95.
19.
BoguszewskiCLHynsjoLJohannssonGBengtssonB-ACarlssonLMS. 22 kD Growth hormone exclusion assay: a new approach to measurement of non-22 kD growth hormone isoforms in human blood. Eur J Endocrinol1996;135: 573–82.
20.
BoguszewskiCLJanssonCBoguszewskiMCRosbergSCarlssonBAlbertsson-WicklandKIncreased proportion of circulating non-22-kilodalton isoforms in short children: a possible mechanism for growth failure. J Clin Endocrinol Metab1997;2: 2944–9.
21.
BoguszewskiCLJohanssonGBengtssonBAJohanssonACarlssonBCarlssonLM. Circulating non-22-kilodalton growth hormone isoforms in acromegalic men before and after transsphenoidal surgery. J Clin Endocrinol Metab1997;82: 1516–21.
22.
TsushimaTKatohYMiyachiYChiharaKTeramotoAIrieMSerum concentration of 20 K human growth hormone (20K hGH) measured by a specific enzyme-linked immunosorbent assay. J Clin Endocrinol Metab1999;84: 317–22.
23.
IshikawaMYokotaSTachibanaKHasegawaYYasudaTTokuhiroESerum levels of 20-kilodalton human growth hormone (GH) are parallel those of 22-kilodalton human GH in normal and short children. J Clin Endorinol Metab1999;84: 98–104.
24.
CunninghamBCUltshMdeVosAMMullkerrinNGClauserICRWellsJA. Dimerisation of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science1991;254: 821–5.
StrasburgerCJWuZPflaumC-DDressendorferRA. Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for qualitative hGH measurement. J Clin Endocrinol Metab1996;81: 2613–20.
27.
MercadoMCarlssonLVitangcolRBaumannG.Growth hormone binding protein determination in plasma: a comparison of immunofunctional and growth hormone-binding assays. J Clin Endocrinol Metab1993;76: 1291–4.
28.
GlennCChamberlinAWoodP.Immunofunctional and immunometric serum growth hormone assays compared for the assessment of stimulation test responses. J Endocrinol1999;163 (Suppl): P32.
29.
SethJEllisAAl-SadieR.Serum growth hormone measurements in clinical practice: An audit of performance from the UK National External Quality Assessment Scheme. Horm Res1999;51 (Suppl 1): 13–9.
30.
ChatelainPBouillatBCohenRSassolasGSouberbielleJCRuiltonAAssay of growth hormone levels in human plasma using commercial kits: analysis of some factors influencing the results. Acta Paediatr Scand1990;370 (Suppl): 56–61.
31.
BowsherRRApathyJMFergusonACRigginRMHenryDP. Cross-reactivity of monomeric and dimeric biosynthetic human growth hormone in a commercial immunoassay. Clin Chem1990;36: 362–6.
32.
CampinoCSzecowkaJMichelsonHSeron-FerrM.Certain large forms of circulating immunoreactive human growth hormone are in fact immunoglobulins. J Clin Endocrinol Metab1990;70: 601–5.
33.
FelderRAHallRWMarthaPJrBarkerGHellmanPWillsMRInfluence of matrix on concentrations of somatotropin measured in serum with commercial immunoradiometric assays. Clin Chem1989;35: 1423–6.
34.
JanTShawMABaumannG.Effects of growth hormone-binding proteins on serum growth hormone measurements. J Clin Endocrinol Metab1991;72: 381–91.
35.
FiskerSEbdrupLUrskovH.Influence of growth hormone binding protein on growth hormone estimation in different immunoassays. Scand J Clin Lab Invest1998;58: 373–81.
36.
EbdrupLFiskerSSorensenHHRankeMBUrskovH.Variety in growth hormone determinations due to use of different immunoassays and the interference of growth hormone binding protein. Horm Res1999;51 (Suppl 1): 20–6.
37.
MilnerRDGRussell-FraserTBrookCGD. Experience with human growth hormone in Great Britain: the report of the MRC Working Party. Clin Endocrinol1979;11: 15–38.
38.
DattaniMTPringlePJHindmarshPCBrookCGD. What is a normal stimulated growth hormone concentration?J Endocrinol1992;133: 447–50.
39.
NanduriVDaviesHJonesJ.Diagnosis of human growth hormone deficiency: an assay dependent phenomenon? Programme and abstracts of the 10th International Congress of Endocrinology, 1996: P2–289.
40.
AnderssonA-MOskovHRankeMBShaletSSkakkebaekNS. Interpretation of growth hormone provocative tests: comparison of cut-off values in four European laboratories. Eur J Endocrinol1995;132: 340–3.
41.
RankeMBOrskovHBristowAFSethJBaumannG.Consensus on how to measure growth hormone in serum. Horm Res1999;51 (Suppl 1): 27–9.
